Discovery of Mdm2-MdmX E3 Ligase Inhibitors Using a Cell-Based Ubiquitination Assay is a research paper published in Cancer Discovery (2011). On theSindex it has a DataRank of 0.694. It has been cited 101 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.694
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIMH NIH HHS
Grant: 1R03MH082369
NCI NIH HHS
Grant: 5R01CA097061
NIGMS NIH HHS
Grant: 5R01GM085081
NIMH NIH HHS
Grant: R03 MH082369
NCI NIH HHS
Grant: T32 CA009503
NIGMS NIH HHS
Grant: T32 GM008281
NCI NIH HHS
Grant: R01 CA097061
NCI NIH HHS
Grant: 5R01CA058316-17
NCI NIH HHS
Grant: R01 CA058316
NIGMS NIH HHS
Grant: R01 GM085081
Howard Hughes Medical Institute
Howard Hughes Medical Institute
FWCI
2.34
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals